Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 1131-1141

  Kuerer, Henry M ^a   Lari, Sara A ^a   Arun, Banu K ^a   Hu, Chung Yuan ^a   Brewster, Abenaa ^a   Mittendorf, Elizabeth A ^a   Albarracin, Constance T ^a   Babiera, Gildy V ^a   Caudle, Abigail S ^a   Wagner, Jamie L ^a   Litton, Jennifer K ^a   Bedrosian, Isabelle ^a   Meric Bernstam, Funda ^a   Lucci, Anthony ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Body mass index; Breast cancer; DCIS; Metformin; Obesity

Indexed keywords

METFORMIN; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CANCER RECURRENCE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; FOLLOW UP; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; OBESITY; PATIENT CODING; POSTMENOPAUSE; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SYMPTOM; UNDERWEIGHT;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OBESITY; PROGNOSIS; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 84863727061     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-1999-3     Document Type: Article

References (31)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241. doi:10.1001/jama.2009. 2014
2. Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13:71-76. doi: 10.1007/s11912-010-0139-7
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638. doi: 10.1056/NEJMoa021423
4. Chen X, Lu W, Zheng W, Gu K, Chen Z, Zheng Y, Shu XO (2010) Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 122:823-833. doi:10.1007/s 10549-009-0708-3
5. Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, Cristofanilli M (2008) Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 14:1718-1725. doi:10.1158/1078-0432.CCR-07-1479
6. de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JP, Vicente M, Giuliani R, Nordenskjold B, Gutierez J, Andersson M, Vila MM, Jakesz R, Demol J, Dewar J, Santoro A, Lluch A, Olsen S, Gelber RD, Di Leo A, Piccart-Gebhart M (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat 119:145-153. doi:10.1007/s10549- 009-0512-0
7. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29:25-31. doi:10.1200/JCO.2010.29.7614
8. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA (2005) Obesity and outcomes in pre-menopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686-1691. doi:10.1158/1055-9965.EPI-05-0042
9. Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, Decensi A (2009) Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev 18:701-705. doi:10.1158/1055-9965.EPI-08-0871
10. Goodwin PJ, Stambolic V, Lemieux J, Chen BE, Parulekar WR, Gelmon KA, Hershman DL, Hobday TJ, Ligibel JA, Mayer IA, Pritchard KI, Whelan TJ, Rastogi P, Shepherd LE (2011) Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat 126:215-220. doi:10.1007/s10549-010-1224-1
11. Hadad S, Iwamoto T, Jordan L, Purdie C, Bray S, Baker L, Jellema G, Deharo S, Hardie DG, Pusztai L, Moulder-Thompson S, Dewar JA, Thompson AM (2011) Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat 128:783-794. doi:10.1007/s10549-011-1612-1
12. Daniels SR (2009) The use of BMI in the clinical setting. Pediatrics 124(Suppl 1):S35-S41. doi:10.1542/peds.2008-3586F
13. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, Simin L, Robinson JG, Safford MM, Tinker LT, Phillips LS (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5:240-247. doi:10.1177/1740774508091749
14. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467-1476
15. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Ko-enig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-1226
16. Rose DP, Vona-Davis L (2009) Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 9:1091-1101. doi:10.1586/era.09.71
17. Kuerer HM (2011) Rational individualised selection of adjuvant therapy for ductal carcinoma in situ. Lancet Oncol 12:2-3. doi: 10.1016/S1470-2045(10) 70277-1
18. Sestak I, Distler W, Forbes JF, Dowsett M, Howell A, Cuzick J (2010) Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol 28:3411-3415. doi:10.1200/JCO. 2009.27.2021
19. El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W (2007) Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg 245:665-671. doi:10.1097/01.sla.0000245833. 48399.9a
20. Chang DW, Wang B, Robb GL, Reece GP, Miller MJ, Evans GR, Langstein HN, Kroll SS (2000) Effect of obesity on flap and donor-site complications in free transverse rectus abdominis myocutaneous flap breast reconstruction. Plast Reconstr Surg 105:1640-1648
21. McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, Cordeiro PG, Pusic AL (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121:1886-1892. doi:10.1097/PRS.0b013e31817151c4
22. Alderman AK, McMahon L, Wilkins EG (2003) The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg 111:695-703. doi:10.1097/01.Prs. 0000041438.50018.02
23. Sinicrope FA, Dannenberg AJ (2011) Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 29:4-7. doi: 10.1200/JCO.2010.32.1752
24. Canchola AJ, Anton-Culver H, Bernstein L, Clarke CA, Henderson K, Ma H, Ursin G, Horn-Ross PL (2012) Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control. doi: 10.1007/s10552-012-9897-x
25. Hartz A, He T, Rimm A (2012) Comparison of adiposity measures as risk factors in postmenopausal women. J Clin Endocrinol Metab 97:227-233. doi:10.1210/jc.2011-1151
26. McTiernan A, Irwin M, Vongruenigen V (2010) Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28:4074-4080. doi:10.1200/JCO.2010.27.9752
27. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kel-emen LE, Folsom AR, Sellers TA (2005) Association of gain and loss of weight before and after menopause with risk of post-menopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14:656-661. doi:10.1158/1055-9965.EPI- 04-0001
28. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296:193-201. doi:10.1001/jama.296.2.193
29. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V (1997) Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89:76-82
30. Reinier KS, Vacek PM, Geller BM (2007) Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre-and post-menopausal women. Breast Cancer Res Treat 103:343-348. doi:10.1007/s10549- 006-9375-9
31. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9:697-703